347 related articles for article (PubMed ID: 31884717)
1. Recent advances in cardio-oncology: a report from the 'Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019'.
Anker MS; Hadzibegovic S; Lena A; Belenkov Y; Bergler-Klein J; de Boer RA; Farmakis D; von Haehling S; Iakobishvili Z; Maack C; Pudil R; Skouri H; Cohen-Solal A; Tocchetti CG; Coats AJS; Seferović PM; Lyon AR;
ESC Heart Fail; 2019 Dec; 6(6):1140-1148. PubMed ID: 31884717
[TBL] [Abstract][Full Text] [Related]
2. Modern-day cardio-oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018'.
Anker MS; Lena A; Hadzibegovic S; Belenkov Y; Bergler-Klein J; de Boer RA; Cohen-Solal A; Farmakis D; von Haehling S; López-Fernández T; Pudil R; Suter T; Tocchetti CG; Lyon AR;
ESC Heart Fail; 2018 Dec; 5(6):1083-1091. PubMed ID: 30570223
[TBL] [Abstract][Full Text] [Related]
3. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
Lyon AR; Dent S; Stanway S; Earl H; Brezden-Masley C; Cohen-Solal A; Tocchetti CG; Moslehi JJ; Groarke JD; Bergler-Klein J; Khoo V; Tan LL; Anker MS; von Haehling S; Maack C; Pudil R; Barac A; Thavendiranathan P; Ky B; Neilan TG; Belenkov Y; Rosen SD; Iakobishvili Z; Sverdlov AL; Hajjar LA; Macedo AVS; Manisty C; Ciardiello F; Farmakis D; de Boer RA; Skouri H; Suter TM; Cardinale D; Witteles RM; Fradley MG; Herrmann J; Cornell RF; Wechelaker A; Mauro MJ; Milojkovic D; de Lavallade H; Ruschitzka F; Coats AJS; Seferovic PM; Chioncel O; Thum T; Bauersachs J; Andres MS; Wright DJ; López-Fernández T; Plummer C; Lenihan D
Eur J Heart Fail; 2020 Nov; 22(11):1945-1960. PubMed ID: 32463967
[TBL] [Abstract][Full Text] [Related]
4. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
[TBL] [Abstract][Full Text] [Related]
5. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
[TBL] [Abstract][Full Text] [Related]
6. European Society of Cardiology Core Curriculum for cardio-oncology.
López-Fernández T; Farmakis D; Ameri P; Asteggiano R; de Azambuja E; Aznar M; Barac A; Bayes-Genis A; Bax JJ; Bergler-Klein J; Boriani G; Celutkiene J; Coats A; Cohen-Solal A; Córdoba R; Cosyns B; Filippatos G; Fox K; Gulati G; Inciardi RM; Lee G; Mamas MA; Novo G; Plummer C; Psyrri A; Rakisheva A; Suter T; Tini G; Tocchetti CG; Toutouzas K; Wilhelm M; Metra M; Lyon AR; Rosano GMC
Eur J Heart Fail; 2024 Apr; 26(4):754-771. PubMed ID: 38059343
[TBL] [Abstract][Full Text] [Related]
7. Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of Cardiology.
Nobre Menezes M; Tavares da Silva M; Magalhães A; Melica B; Toste JC; Calé R; Almeida M; Fiuza M; Infante de Oliveira E
Rev Port Cardiol; 2024 Jan; 43(1):35-48. PubMed ID: 37482119
[TBL] [Abstract][Full Text] [Related]
8. Organization and implementation of a cardio-oncology program.
Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
[TBL] [Abstract][Full Text] [Related]
9. Cardio-oncology in the older adult.
Reddy P; Shenoy C; Blaes AH
J Geriatr Oncol; 2017 Jul; 8(4):308-314. PubMed ID: 28499724
[TBL] [Abstract][Full Text] [Related]
10. [The Cardio-Oncology Guideline - A Comprehensive Approach to Managing Cardiovascular Risks in Cancer Patients].
Romann SW; Frey N; Lehmann L
Dtsch Med Wochenschr; 2024 Jun; 149(12):719-723. PubMed ID: 38781996
[TBL] [Abstract][Full Text] [Related]
11. Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology.
Liang Z; He Y; Hu X
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142538
[TBL] [Abstract][Full Text] [Related]
12. Comparison of American and European guidelines for cardio-oncology of heart failure.
Chen JZ; Liang B
Heart Fail Rev; 2023 Sep; 28(5):1211-1220. PubMed ID: 36912998
[TBL] [Abstract][Full Text] [Related]
13. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
[TBL] [Abstract][Full Text] [Related]
14. Emergence of cardio-oncology.
Nebigil CG; Désaubry L
Ann Pharm Fr; 2018 Nov; 76(6):504-506. PubMed ID: 30075937
[TBL] [Abstract][Full Text] [Related]
15. What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist?
Andres MS; Pan J; Lyon AR
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):483-493. PubMed ID: 33832839
[TBL] [Abstract][Full Text] [Related]
16. Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.
Bergler-Klein J; Rainer PP; Wallner M; Zaruba MM; Dörler J; Böhmer A; Buchacher T; Frey M; Adlbrecht C; Bartsch R; Gyöngyösi M; Fürst UM
Wien Klin Wochenschr; 2022 Sep; 134(17-18):654-674. PubMed ID: 35507087
[TBL] [Abstract][Full Text] [Related]
17. Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
de Boer RA; Hulot JS; Tocchetti CG; Aboumsallem JP; Ameri P; Anker SD; Bauersachs J; Bertero E; Coats AJS; Čelutkienė J; Chioncel O; Dodion P; Eschenhagen T; Farmakis D; Bayes-Genis A; Jäger D; Jankowska EA; Kitsis RN; Konety SH; Larkin J; Lehmann L; Lenihan DJ; Maack C; Moslehi JJ; Müller OJ; Nowak-Sliwinska P; Piepoli MF; Ponikowski P; Pudil R; Rainer PP; Ruschitzka F; Sawyer D; Seferovic PM; Suter T; Thum T; van der Meer P; Van Laake LW; von Haehling S; Heymans S; Lyon AR; Backs J
Eur J Heart Fail; 2020 Dec; 22(12):2272-2289. PubMed ID: 33094495
[TBL] [Abstract][Full Text] [Related]
18. [Cancer treatment and risk of heart failure].
Mbarek D; Mirabel M
Rev Prat; 2020 Nov; 70(9):969-974. PubMed ID: 33739752
[TBL] [Abstract][Full Text] [Related]
19. Cardio-oncology: the new frontier of clinical and preventive cardiology.
Paris S; Tarantini L; Navazio A; Faggiano P
Monaldi Arch Chest Dis; 2020 Jun; 90(2):. PubMed ID: 32571000
[TBL] [Abstract][Full Text] [Related]
20. Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers.
Di Lisi D; Cadeddu Dessalvi C; Zito C; Madaudo C; Manganaro R; Mercurio V; Deidda M; Santoro C; Penna C; Monte IP; Spallarossa P; Tocchetti CG; Novo G
Curr Probl Cardiol; 2024 Mar; 49(3):102229. PubMed ID: 38154703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]